Effects of curcumin supplementation on inflammatory biomarkers in patients with Rheumatoid Arthritis and Ulcerative colitis: A systematic review and meta-analysis

被引:23
作者
Ebrahimzadeh, Armin [1 ]
Abbasi, Fatemeh [2 ]
Ebrahimzadeh, Anahita [3 ]
Jibril, Aliyu Tijani [4 ]
Milajerdi, Alireza [1 ,5 ]
机构
[1] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Inst Basic Sci, POB 87159-81151, Kashan, Iran
[2] Allameh Tabatabai Univ, Fac Phys Educ & Sports Sci, Dept Sports Injuries, Tehran, Iran
[3] Shiraz Univ Med Sci, Homaijan Hlth Care Ctr, Deputy Hlth, Shiraz, Iran
[4] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran
[5] AJA Univ Med Sci, Dept Hlth, Sci & Res Branch, Tehran, Iran
关键词
Autoimmune disease; Cytokine; Curcumin; Inflammation; Meta-analysis; Rheumatoid arthritis; AGENTS;
D O I
10.1016/j.ctim.2021.102773
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Although previous studies have examined the impact of curcumin supplementation on cytokine levels in patients with autoimmune disorders, we were unable to find a systematic review of the effect of curcumin supplementation on inflammatory biomarkers such as CRP and ESR in patients with rheumatoid arthritis or ulcerative colitis; therefore we conducted this systematic review and meta-analysis. Methods: Relevant studies published from inception to December 2020 were systematically searched through the PubMed, SCOPUS, and google scholar databases. We conducted our systematic review and meta-analysis according to the 2020 PRISMA guidelines. The quality of the papers were assessed by using the Cochrane Collaboration's risk of bias tool. Included studies were randomized clinical trials on the effects of supplementation with curcumin or its derivative on inflammatory factors in patients with rheumatoid arthritis and ulcerative colitis. Pooled effect sizes were calculated using a random-effects model and reported as the weighted mean difference (WMD) and 95 % CI. Results: In all, six studies met the inclusion criteria for this study. Curcumin supplementation in doses of 250-1500 mg/day over 8-12 weeks was observed to be associated with decreases in CRP and ESR in adult patients with rheumatoid arthritis and ulcerative colitis in comparison with the control group (WMD: -0.42; 95 % CI: -0.59, - 0.26, I2 = 94.3 %; WMD: -55.96; 95 % CI: -93.74, -18.17, I2 = 99.7 %, respectively). Significant findings were also observed based on subgroup analyses by the study sample size, duration, participants' age, curcumin dosage, and type of disease. Conclusions: Curcumin supplementation was associated with significant reductions in levels of CRP and ESR in patients with rheumatoid arthritis and ulcerative colitis. Earlier studies reported curcumin as a safe complementary therapy for several diseases. However, a handful of studies were found on the effect of curcumin on autoimmune diseases despite our comprehensive search. Further studies are therefore warranted in this area.
引用
收藏
页数:8
相关论文
共 41 条
  • [31] NLRP3: A promising therapeutic target for autoimmune diseases
    Shen, Hui-Hui
    Yang, Yue-Xin
    Meng, Xiang
    Luo, Xiao-Yun
    Li, Xiao-Mei
    Shuai, Zong-Wen
    Ye, Dong-Qing
    Pan, Hai-Feng
    [J]. AUTOIMMUNITY REVIEWS, 2018, 17 (07) : 694 - 702
  • [32] Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
    Smolen, Josef S.
    Aletaha, Daniel
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (05) : 276 - 289
  • [33] Complementary medicine use in the Australian population: Results of a nationally-representative cross-sectional survey
    Steel, Amie
    McIntyre, Erica
    Harnett, Joanna
    Foley, Hope
    Adams, Jon
    Sibbritt, David
    Wardle, Jon
    Frawley, Jane
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [34] The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials
    Tabrizi, Reza
    Vakili, Sina
    Akbari, Maryam
    Mirhosseini, Naghmeh
    Lankarani, Kamran B.
    Rahimi, Maryam
    Mobini, Moein
    Jafarnejad, Sadegh
    Vahedpoor, Zahra
    Asemi, Zatollah
    [J]. PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 253 - 262
  • [35] Modern Therapeutic Strategies for Autoimmune Diseases
    Tyndall, Alan
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (29) : 4508 - 4512
  • [36] Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial
    Vors, Cecile
    Couillard, Charles
    Paradis, Marie-Eve
    Gigleux, Iris
    Marin, Johanne
    Vohl, Marie-Claude
    Couture, Patrick
    Lamarche, Benoit
    [J]. JOURNAL OF NUTRITION, 2018, 148 (03) : 379 - 388
  • [37] Human autoimmune diseases: a comprehensive update
    Wang, Lifeng
    Wang, Fu-Sheng
    Gershwin, M. Eric
    [J]. JOURNAL OF INTERNAL MEDICINE, 2015, 278 (04) : 369 - 395
  • [38] Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction
    Wang, Ning-Ping
    Wang, Zhang-Feng
    Tootle, Stephanie
    Philip, Tiji
    Zhao, Zhi-Qing
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (07) : 1550 - 1562
  • [39] Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials
    White, C. Michael
    Pasupuleti, Vinay
    Roman, Yuani M.
    Li, Yangzhou
    Hernandez, Adrian V.
    [J]. PHARMACOLOGICAL RESEARCH, 2019, 146